HealthEquity, Inc. (NASDAQ:HQY) Vice Chairman Sells $2,795,100.00 in Stock

HealthEquity, Inc. (NASDAQ:HQY) Vice Chairman Stephen Neeleman sold 35,000 shares of the business’s stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $79.86, for a total value of $2,795,100.00. Following the completion of the sale, the insider now directly owns 89,769 shares of the company’s stock, valued at $7,168,952.34. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Stephen Neeleman also recently made the following trade(s):

• On Friday, June 7th, Stephen Neeleman sold 2,080 shares of HealthEquity stock. The shares were sold at an average price of $85.01, for a total value of $176,820.80.
• On Tuesday, June 4th, Stephen Neeleman sold 400 shares of HealthEquity stock. The shares were sold at an average price of $85.00, for a total value of $34,000.00.

HealthEquity Stock Down 1.7 %

Shares of HealthEquity stock traded down $1.37 during trading hours on Monday, hitting $79.61. 592,346 shares of the company’s stock traded hands, compared to its average volume of 621,090. The stock has a 50 day simple moving average of $81.45 and a 200-day simple moving average of $80.05. The company has a quick ratio of 4.39, a current ratio of 4.39 and a debt-to-equity ratio of 0.44. The company has a market cap of $6.93 billion, a PE ratio of 88.02, a PEG ratio of 1.36 and a beta of 0.57. HealthEquity, Inc. has a twelve month low of $61.81 and a twelve month high of $88.26.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Monday, June 3rd. The company reported $0.55 earnings per share for the quarter, beating the consensus estimate of $0.47 by $0.08. The company had revenue of $287.60 million during the quarter, compared to the consensus estimate of $278.78 million. HealthEquity had a return on equity of 7.77% and a net margin of 7.71%. Equities research analysts anticipate that HealthEquity, Inc. will post 2.12 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several analysts have recently weighed in on HQY shares. Bank of America reissued a “buy” rating and issued a $105.00 target price on shares of HealthEquity in a report on Wednesday, July 3rd. Barrington Research boosted their target price on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a report on Tuesday, June 4th. KeyCorp upped their price objective on HealthEquity from $95.00 to $100.00 and gave the company an “overweight” rating in a research note on Wednesday, June 5th. Royal Bank of Canada reiterated an “outperform” rating and set a $92.00 target price on shares of HealthEquity in a research report on Tuesday, June 4th. Finally, Wells Fargo & Company upped their price target on HealthEquity from $107.00 to $110.00 and gave the stock an “overweight” rating in a report on Thursday, June 20th. One equities research analyst has rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $101.67.

Institutional Trading of HealthEquity

Several large investors have recently modified their holdings of the business. ABLE Financial Group LLC grew its stake in HealthEquity by 5.8% in the second quarter. ABLE Financial Group LLC now owns 17,324 shares of the company’s stock worth $1,493,000 after purchasing an additional 955 shares in the last quarter. Allspring Global Investments Holdings LLC grew its stake in HealthEquity by 0.8% in the second quarter. Allspring Global Investments Holdings LLC now owns 1,122,057 shares of the company’s stock worth $96,721,000 after purchasing an additional 9,125 shares in the last quarter. Bank of New York Mellon Corp grew its stake in HealthEquity by 12.3% in the second quarter. Bank of New York Mellon Corp now owns 901,174 shares of the company’s stock worth $77,681,000 after purchasing an additional 98,994 shares in the last quarter. EFG Asset Management North America Corp. acquired a new position in HealthEquity in the second quarter worth about $1,427,000. Finally, Overbrook Management Corp acquired a new position in HealthEquity in the second quarter worth about $12,284,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.